Pre-emption: Obama Administration Creeps Towards Reversing FDA Stance
Executive Summary
FDA has not yet altered its support of pre-emption in product liability suits but there are signs it may do so under the Obama administration
You may also be interested in...
Vaccine Liability Question Is Urgent, Gov't. Says; Supreme Court Takes Up Case
At the encouragement of the government, the U.S. Supreme Court agreed to take up the question of whether a federal law shields vaccine manufacturers from all liability for alleged vaccine design defects
Vaccine Liability Question Is Urgent, Gov't. Says; Supreme Court Takes Up Case
At the encouragement of the government, the U.S. Supreme Court agreed to take up the question of whether a federal law shields vaccine manufacturers from all liability for alleged vaccine design defects
Pharma Outside the Fray As Obama Re-Evaluates Bush’s Pre-emption Policy
The good news for drug firms about President Obama's memo curtailing federal pre-emption state laws: it won't have any real impact on industry. The bad news: it won't matter because pre-emption in the Rx arena was already dealt a body blow in the Supreme Court's recent ruling in Wyeth v. Levine